Safer injection facility use and syringe sharing in injection drug users
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Safer injection facilities provide medical supervision for illicit drug injections. We aimed to examine factors associated with syringe sharing in a community-recruited cohort of illicit injection drug users in a setting where such a facility had recently opened. Between Dec 1, 2003, and June 1, 2004, of 431 active injection drug users 49 (11.4%, 95% CI 8.5-14.3) reported syringe sharing in the past 6 months. In logistic regression analyses, use of the facility was independently associated with reduced syringe sharing (adjusted odds ratio 0.30, 0.11-0.82, p=0.02) after adjustment for relevant sociodemographic and drug-use characteristics. These findings could help inform discussions about the merits of such facilities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While several studies have pointed to the positive impact of the SIF on public disorder [15], HIV risk behaviour [16], management of overdose [17,18] and use of addiction treatment [19], its role with regard to hospitalization for CIRI remains unknown.”
From Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study (2010) · cites this paper as [16]
In the citing paper
“This may reflect prompt referral as well as the preventative effect of the SIF on serious infections [16].”
From Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study (2010) · cites this paper as [16]
Citations
Cites
Wood, E. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040774 · Cited by 267
Self-citationWood, E., TYNDALL, M. W., Spittal, P. M., Li, K. K., Kerr, T. H., Hogg, R. S., Montaner, J. S. G., O’Shaughnessy, M. V., & Schechter, M. T. (2001) · PubMed Central · Cited by 230
Self-citationWood, E., Tyndall, M. W., Spittal, P. M., Li, K., Hogg, R. S., Montaner, J. S. G., O'Shaughnessy, M. V., & Schechter, M. T. (2002) · AIDS · doi:10.1097/00002030-200204120-00021 · Cited by 146
Self-citationEuropean report on drug consumption rooms.
Hedrich, D. (2004) · Cited by 144
Rationale for evaluating North America's first medically supervised safer-injecting facility
Wood, E., Kerr, T. H., Montaner, J. S. G., Strathdee, S. A., WODAK, A. D., Hankins, C. A., Schechter, M. T., & TYNDALL, M. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01006-0 · Cited by 113
Self-citationKerr, T. H., Palepu, A., Barnes, G. E., Walsh, J. C., Hogg, R. S., Montaner, J. S. G., TYNDALL, M. W., & Wood, E. (2004) · Antiviral Therapy · doi:10.1177/135965350400900314 · Cited by 76
Self-citationCarella, A. M., Beltrami, G., Corsetti, M. T., Nati, S., Musto, P., Scalzulli, P. R., Gonella, R., Ballestrero, A., & Patrone, F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66989-9 · Cited by 61
Wright, N. M. J., & Tompkins, C. N. E. (2004) · BMJ · doi:10.1136/bmj.328.7431.100 · Cited by 46
Cited by
Public health and international drug policy
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00619-x · Cited by 641
Self-citationSupervised injection services: What has been demonstrated? A systematic literature review
Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.012 · Cited by 495
Marshall, B. D., Milloy, M.-J., Wood, E., Montaner, J. S., & Kerr, T. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62353-7 · Cited by 479
Self-citationWood, E., Kerr, T., Marshall, B. D. L., Li, K., Zhang, R., Hogg, R. S., Harrigan, P. R., & Montaner, J. S. G. (2009) · BMJ · doi:10.1136/bmj.b1649 · Cited by 342
“Between 1 May 1996 and 30 June 2007, injecting drug users with and without HIV were recruited into a prospective cohort study from the Downtown Eastside neighbourhood of Vancouver, Canada. Individuals were recruited regardless of HIV status and followed up every six months. Two virtual cohorts were created at the data…”
Self-citationRITTER, A., & CAMERON, J. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944529 · Cited by 300
Metadata
- Authors
- Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Kerr, Thomas
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 366
- Issue
- 9482
- Pages
- 316-318
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2161959198
- Cited by
- 294
- References
- 8
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 14 · 2023: 7 · 2022: 14 · 2021: 7 · 2020: 11 · 2019: 11 · 2018: 14 · 2017: 18 · 2016: 9 · 2015: 12 · 2014: 13 · 2013: 12 · 2012: 16
- FWCI
- 17.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Health and Medical Research Council
- National Medical Research Council
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Sociology and Political Science › Homelessness and Social Issues
- Keywords
- needle sharing, people who inject drugs, harm reduction, risk factors
- MeSH terms
- Humans, Opioid-Related Disorders, Public Facilities, Risk-Taking, HIV Infections, Substance Abuse, Intravenous, Blood-Borne Pathogens, Needle-Exchange Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safer injection facility use and syringe sharing in injection drug users. https://app.cochat.ai/papers/10.1016/s0140-6736(05)66475-6
- The paper
- Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. The Lancet. https://doi.org/10.1016/s0140-6736(05)66475-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.